Anti-obesity activity of hen egg anti-lipase immunoglobulin yolk, a novel pancreatic lipase inhibitor

Nutrition and Metabolism

Volumn 10, Issue 1, 2013, Pages

  Hirose, Mai ^a   Ando, Taishi ^a   Shofiqur, Rahman ^b   Umeda, Kouji ^b   Kodama, Yoshikatsu ^b   Nguyen, Sa Van ^b   Goto, Tsuyoshi ^a   Shimada, Masaya ^a   Nagaoka, Satoshi ^a  

^a GIFU UNIVERSITY   (Japan)

^b Immunol Research Institute in Gifu   (Japan)

Author keywords

IgY; Lipid; Mice; Obesity; Pancreatic lipase

Indexed keywords

CHOLESTEROL; IMMUNOGLOBULIN Y; LIPID; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE;

ADIPOSE TISSUE; ANIMAL MODEL; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DIARRHEA; DRUG ISOLATION; ENZYME INHIBITION; EPIDIDYMIS FAT; FECES; IC 50; IN VITRO STUDY; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; RETROPERITONEAL FAT; SYSTEMATIC REVIEW; WEIGHT GAIN;

MURINAE; MUS; SUS;

EID: 84889773272     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-10-70     Document Type: Article

References (32)

1. Pancreatic lipase inhibitors from natural sources: unexplored potential. Birari RB, Bhutani KK, Drug Discov Today 2007 12 879 889 10.1016/j.drudis.2007. 07.024 17933690 (Pubitemid 47539967)
2. Orlistat: its current status as an anti-obesity drug. Ballinger A, Peikin SR, Eur J Pharmacol 2002 440 109 117 10.1016/S0014-2999(02)01422-X 12007529 (Pubitemid 34458018)
3. (-)-Epigallocatechin-3-gallate inhibits pancreatic lipase and reduces body weight gain in high fat-fed obese mice. Grove KA, Sae-tan S, Kennett MJ, Lambert JD, Obesity 2012 20 2311 2313 10.1038/oby.2011.139 21633405
4. Prevention of diet-induced obesity by dietary black tea polyphenols extract in vitro and in vivo. Uchiyama S, Taniguchi Y, Saka A, Yoshida A, Yajima H, Nutrition 2011 27 287 292 10.1016/j.nut.2010.01.019 20627658
5. Use of egg yolk-derived immunoglobulin as an alternative to antibiotic treatment for control of Helicobacter pylori Infection. Shin JH, Yang M, Nam SW, Kim JT, Myung NH, Bang WG, Roe IH, Clin Diagn Lab Immunol 2002 9 1061 1066 12204960 (Pubitemid 34988476)
6. Acid stability of anti-Helicobacter pyroli IgY in aqueous polyol solution. Lee KA, Chang SK, Lee YJ, Lee JH, Koo NS, J Biochem Mol Biol 2002 35 488 493 10.5483/BMBRep.2002.35.5.488 12359091
7. Oral passive immunization effect of anti-human rotavirus IgY and its behavior against proteolytic enzymes. Hatta H, Tsuda K, Akachi S, Kim M, Yamamoto T, Ebina T, Biosci Biotechnol Biochem 1993 57 1077 1081 10.1271/bbb.57.1077 7764069
8. Oral passive IgY-based immunotherapeutics: a novel solution for prevention and treatment of alimentary tract diseases. Rahman S, Nguyen SV, Icatlo FC Jr, Umeda K, Kodama Y, Hum Vaccin Immunother 2013 14 1039 1048
9. Passive oral immunization by egg yolk immunoglobulin (IgY) to Vibrio cholerae effectively prevents cholera. Hirai K, Arimitsu H, Umeda K, Yokota K, Shen L, Ayada K, Kodama Y, Tsuji T, Hirai Y, Oguma K, Acta Med Okayama 2010 64 163 170 20596127
10. In vitro and in vivo effectiveness of egg yolk antibody against Candida albicans (anti-CA IgY). Ibrahim ESM, Rahman AK, Isoda R, Umeda K, Nguyen SV, Kodama Y, Vaccine 2008 26 2073 2080 18375022
11. Specific egg yolk immunoglobulin as a new preventive approach for Shiga-toxin-mediated diseases. Neri P, Tokoro S, Kobayashi R, Sugiyama T, Umeda K, Shimizu T, Tsuji T, Kodama Y, Oguma K, Mori H, PLoS ONE 2011 6 26526 10.1371/journal.pone.0026526 22028896
12. Randomized placebo-controlled clinical trial of immunoglobulin Y as adjunct to standard supportive therapy for rotavirus-associated diarrhea among pediatric patients. Rahman S, Higo MK, Htunc KW, Taniguchi K, Icatlo FC, Tsuji T, Kodama Y, Nguyen SV, Umeda K, Oo HN, Myint YY, Htut T, Myint SS, Thura K, Thu HM, Fatmawati NND, Oguma K, Vaccine 2012 30 4661 4669 10.1016/j.vaccine.2012. 04.091 22575165
13. Porcine pancreatic lipase. A glycoprotein. Garner CW, Smith LC, J Biol Chem 1972 247 561 565 5009700
14. Effect of oral egg antibody in experimental F18+ Escherichia coli infection in weaned pigs. Yokoyama H, Hashi T, Umeda K, Icatlo FC Jr, Kuroki M, Ikemori Y, Kodama Y, J Vet Med Sci 1997 59 917 921 10.1292/jvms.59.917 9362041 (Pubitemid 127524326)
15. Passive protection against bovine rotavirus-induced diarrhea in murine model by specific immunoglobulins from chicken egg yolk. Kuroki M, Ikemori Y, Yokoyama H, Peralta RC, Icatlo FC, Kodama Y, Vet Microbiol 1993 37 135 146 10.1016/0378-1135(93)90188-D 8296443
16. Affinity purification of Helicobacter pylori urease. Relevance to gastric mucin adherence by urease protein. Icatlo FC, Kuroki M, Kobayashi C, Yokoyama H, Ikemori Y, Hashi T, Kodama Y, J Biol Chem 1998 273 18130 18138 10.1074/jbc.273.29.18130 9660771 (Pubitemid 28334730)
17. Antiobesity action of epsilon-polylysine, a potent inhibitor of pancreatic lipase. Tsujita T, Takaichi H, Takaku T, Aoyama S, Hiraki J, J Lipid Res 2006 47 1852 1858 10.1194/jlr.M600168-JLR200 16723640 (Pubitemid 44222836)
18. A simple method for the isolation and purification of total lipids from animal tissues. Folch J, Lees M, Sloane Stanley GH, J Biol Chem 1957 226 497 509 13428781
19. Soy protein peptic hydrolysate with bound phospholipids decrease micellar solubility and cholesterol absorption in rats and Caco-2 cells. Nagaoka S, Miwa K, Eto M, Kuzuya Y, Hori G, Yamamoto K, J Nutr 1999 129 1725 1730 10460211 (Pubitemid 29406628)
20. The Kolmogorov-Smirnov test for the log-normality of sample cumulative frequency distributions. Ong LD, LeClare PC, Health Phys 1968 14 376
21. An application of the Kolmogorov-Smirnov test for normality with estimated mean and variance. Rosenthal R, Psychol Rep 1968 22 570 10.2466/pr0.1968.22.2.570 5650254
22. Statistical methods. Snedecor GW, Cochran WG, Ames, Japanese Edition: Iwanami Pub. Inc Tokyo: The Iowa State University Press 6 1967
23. Identification of the active-site serine in human pancreatic lipase by chemical modification with tetrahydrolipstatin. Luthi-Peng Q, Märki HP, Hadváry P, FEBS Lett 1992 299 111 115 10.1016/0014-5793(92)80112-T 1544468
24. Orlistat-associated adverse effects and drug interactions a critical review. Filippatos TD, Derdemezis CS, Gazi IF, Nakou ES, Mikhailidis DP, Elisaf MS, Drug Saf 2008 31 53 65 10.2165/00002018-200831010-00005 18095746
25. Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers. Carrière F, Renou C, Ransac S, Lopez V, de Caro J, Ferrato F, de Caro A, Fleury A, Sanwald DP, Lengsfeld H, Beglinger C, Hadvary P, Verger R, Laugier R, Am J Physiol Gastrointest Liver Physiol 2001 281 16 G28 11408251
26. Effects of Arachis hypogaea nutshell extract on lipid metabolic enzymes and obesity parameters. Moreno DA, Ilic N, Poulev A, Raskin I, Life Sci 2006 78 2797 2803 10.1016/j.lfs.2005.11.012 16337240
27. C57Bl/6 N mice on a western diet display reduced intestinal and hepatic cholesterol levels despite a plasma hypercholesterolemia. Desmarchelier C, Dahlhoff C, Keller S, Sailer M, Jahreis G, Daniel H, BMC Genomics 2012 13 84 10.1186/1471-2164-13-84 22394543
28. New pharmacological approaches for obesity management. Rueda-Clausen CF, Padwal RS, Sharma AM, Nat Rev Endocrinol 2013 9 467 478 10.1038/nrendo.2013.113 23752772
29. Quinoa extract enriched in 20-hydroxyecdysone protects mice from diet-induced obesity and modulates adipokines expression. Foucault AS, Mathe V, Lafont R, Even P, Dioh W, Veillet S, Tome D, Huneau JF, Hermier D, Boulange AQ, Obesity 2012 20 270 277 10.1038/oby.2011.257 21869758
30. Methionine-restricted C57BL/6 J mice are resistant to diet-induced obesity and insulin resistance but have low bone density. Ables GP, Perrone CE, Orentreich D, Orentreich N, PLoS One 2012 7 51357 10.1371/journal.pone.0051357 23236485
31. Impact of increased PPARγ activity in adipocytes in vivo on adiposity, insulin sensitivity and the effects of rosiglitazone treatment. Takasawa K, Kubota N, Terauchi Y, Kadowaki T, Endocr J 2008 55 767 776 10.1507/endocrj.K08E-018 18506083
32. Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults. Heymsfield SB, Segal KR, Hauptman J, Lucas CP, Boldrin MN, Rissanen A, Wilding JP, Sjöström L, Arch Intern Med 2000 160 1321 1326 10.1001/archinte.160.9.1321 10809036 (Pubitemid 30252779)